Intervention recommendations to improve uptake of breast, cervical, and colorectal cancer screening among individuals living with serious mental illness

被引:2
|
作者
Garcia-Alcaraz, Cristian [1 ,2 ,6 ]
Binda, Aleigha [2 ,6 ]
Gordon, Janna R. [4 ]
Alpert, Elizabeth N. [5 ]
Greenwood, Kristina L. [3 ]
Aguilar, Rosa A. Cobian [1 ,2 ,6 ]
Lucido, Nicholas C. [2 ,6 ]
Koes, Dina [6 ]
Atterton, Caroline [3 ]
Plopper, Michael G. [3 ]
Wells, Kristen J. [1 ,2 ]
机构
[1] San Diego State Univ, UC San Diego Joint Doctoral Program Clin Psychol, San Diego, CA 92182 USA
[2] San Diego State Univ, San Diego, CA 92182 USA
[3] Sharp HealthCare, San Diego, CA USA
[4] Univ Chicago, NORC, Chicago, IL USA
[5] Syneos Hlth, Morrisville, NY USA
[6] San Diego State Univ Res Fdn, San Diego, CA USA
关键词
Mental disorders; Serious mental illness; Early detection of cancer; Cancer; Cancer screening; Intervention; WOMEN; MORTALITY; BARRIERS; PATIENT; PEOPLE;
D O I
10.1007/s10552-023-01791-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Few efforts have been made to inform intervention design for increasing the uptake of cancer screening in individuals living with serious mental illness (ILSMI), who have lower cancer screening rates than the general population. This qualitative study explored ILSMI's and their care team member's (CTM) recommendations on the design of a breast, colorectal, and cervical cancer screening intervention for ILSMI.Methods Twenty-five ILSMI (mean age: 71.4 years; 60% female) and 15 CTM (mean age: 45.3 years; 80% female) were recruited through purposive sampling. Semi-structured in-depth interviews were used to collect participants' intervention suggestions. Interviews were recorded, transcribed verbatim, and imported into NVivo. Content analysis and the constant comparison method were used to analyze interview data.Results ILSMI and CTMs provided several salient recommendations. ILSMI should receive disease-specific, logistical, and screening education, and primary care staff should receive education on psychopathology. Mental health providers and patient navigators should be considered as the primary interventionist. The intervention should be delivered where ILSMI receive medical or mental health services, receive community and government services, and/or via various digital media. The intervention should improve the collaboration, communication, and coordination between primary and mental health care. Findings also pointed to the implementation of trauma-informed cancer care and integrated care models comprising mental health care and primary cancer care.Conclusion These findings bring the skills, knowledge, and expertise of ILSM and their care team to intervention design for increasing colorectal, breast, and cervical cancer screening in ILSMI attending an intensive outpatient program.
引用
收藏
页码:451 / 463
页数:13
相关论文
共 50 条
  • [41] Breast and cervical cancer-screening uptake among females in Ardabil, northwest Iran: a community-based study
    Farzaneh, Esmaeil
    Heydari, Heshmatolah
    Shekarchi, Ali Akbar
    Kamran, Aziz
    ONCOTARGETS AND THERAPY, 2017, 10 : 985 - 992
  • [42] Disparities in Meeting USPSTF Breast, Cervical, and Colorectal Cancer Screening Guidelines Among Women in the United States
    Benavidez, Gabriel A.
    Zgodic, Anja
    Zahnd, Whitney E.
    Eberth, Jan M.
    PREVENTING CHRONIC DISEASE, 2021, 18 : E37
  • [43] Examining colorectal cancer screening uptake and health provider recommendations among underserved middle aged and older African Americans
    Cobb, Sharon
    Ekwegh, Tavonia
    Adinkrah, Edward
    Ameli, Hoorolnesa
    Dillard, Attallah
    Kibe, Lucy W.
    Bazargan, Mohsen
    HEALTH PROMOTION PERSPECTIVES, 2022, 12 (04): : 399 - 409
  • [44] Experiences of Everyday Life among Individuals with Co-Existence of Serious Mental Illness and Cancer-A Qualitative Systematic Literature Review
    Glasdam, Stinne
    Hybholt, Lisbeth
    Stjernsward, Sigrid
    HEALTHCARE, 2023, 11 (13)
  • [45] Intervention Mediators in a Randomized Controlled Trial to Increase Colonoscopy Uptake Among Individuals at Increased Risk of Familial Colorectal Cancer
    Brumbach, Barbara H.
    Birmingham, Wendy C.
    Boonyasiriwat, Watcharaporn
    Walters, Scott
    Kinney, Anita Y.
    ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 (05) : 694 - 706
  • [46] Development of a Digital Storytelling Intervention to Increase Breast, Cervical, and Colorectal Cancer Screening in the Hispanic/Latino Community: a Qualitative Evaluation
    Lohr, Abby M.
    Capetillo, Graciela Porraz
    Molina, Luz
    Goodson, Miriam
    Smith, Kaitlyn
    Griffin, Joan M.
    Wieland, Mark L.
    Sia, Irene G.
    JOURNAL OF CANCER EDUCATION, 2024, 39 (02) : 160 - 167
  • [47] Development of a Digital Storytelling Intervention to Increase Breast, Cervical, and Colorectal Cancer Screening in the Hispanic/Latino Community: a Qualitative Evaluation
    Abby M. Lohr
    Graciela Porraz Capetillo
    Luz Molina
    Miriam Goodson
    Kaitlyn Smith
    Joan M. Griffin
    Mark L. Wieland
    Irene G. Sia
    Journal of Cancer Education, 2024, 39 : 160 - 167
  • [48] Increasing breast, cervical, and colorectal cancer screening among rural women: Baseline characteristics of a randomized control trial
    Biederman, Erika
    Baltic, Ryan
    Katz, Mira L.
    Rawl, Susan
    Vachon, Eric
    Monahan, Patrick O.
    Stump, Timothy E.
    Kettler, Carla
    Carter, Lisa
    Young, Gregory
    Xu, Wendy
    Paskett, Electra D.
    Champion, Victoria
    CONTEMPORARY CLINICAL TRIALS, 2022, 123
  • [49] Correlates of non-adherence to breast, cervical, and colorectal cancer screening among screen-eligible women: a population-based cohort study in Ontario, Canada
    Vahabi, Mandana
    Lofters, Aisha K.
    Kopp, Alexander
    Glazier, Richard H.
    CANCER CAUSES & CONTROL, 2021, 32 (02) : 147 - 155
  • [50] Uptake of cervical cancer screening among sex workers living with HIV in Nairobi, Kenya: a cross-sectional study
    Akolo, Maureen
    Gelmon, Lawrence
    Musembi, Horatius
    Mutwiri, Benard
    Kambo, Isabel
    Kimani, Joshua
    Akolo, Christopher
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2024, 11